Which test is part of both the blood sugar panel and the diabetic panel?

Prepare for the NPS Phlebotomy Exam. Master skills with multiple-choice questions and detailed explanations. Equip yourself for the test!

Multiple Choice

Which test is part of both the blood sugar panel and the diabetic panel?

Explanation:
The main idea is understanding how different glycemic tests reflect sugar control over different timeframes. Fructosamine measures the amount of glucose attached to serum proteins, mainly albumin. Because these proteins turn over in about 2 to 3 weeks, the fructosamine level provides a snapshot of average blood glucose over roughly the short- to mid-term. This makes it useful in both a blood sugar panel, which looks at recent glucose status, and a diabetic panel, which tracks glycemic control in diabetes management. It’s particularly helpful when HbA1c isn’t reliable or you want a quicker view of glucose control than HbA1c provides. In contrast, HbA1c reflects average glucose over a longer period (about 2–3 months) and is a standard part of long-term diabetes management but isn’t typically the focus of a routine blood sugar panel. Fasting glucose is a single timepoint measure of current glucose, not a broader panel for ongoing glycemic assessment. Lipid panel assesses cholesterol-related values and isn’t a diabetes or blood sugar measure. So fructosamine best fits the idea of being part of both panels because it bridges the short- and medium-term view of glycemic status.

The main idea is understanding how different glycemic tests reflect sugar control over different timeframes. Fructosamine measures the amount of glucose attached to serum proteins, mainly albumin. Because these proteins turn over in about 2 to 3 weeks, the fructosamine level provides a snapshot of average blood glucose over roughly the short- to mid-term. This makes it useful in both a blood sugar panel, which looks at recent glucose status, and a diabetic panel, which tracks glycemic control in diabetes management. It’s particularly helpful when HbA1c isn’t reliable or you want a quicker view of glucose control than HbA1c provides.

In contrast, HbA1c reflects average glucose over a longer period (about 2–3 months) and is a standard part of long-term diabetes management but isn’t typically the focus of a routine blood sugar panel. Fasting glucose is a single timepoint measure of current glucose, not a broader panel for ongoing glycemic assessment. Lipid panel assesses cholesterol-related values and isn’t a diabetes or blood sugar measure. So fructosamine best fits the idea of being part of both panels because it bridges the short- and medium-term view of glycemic status.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy